|Videos|May 31, 2023
Interviews with Tim Tyson of TriRx at DCAT
Author(s)TriRx
Key Learning Objectives
- TriRx is redefining and evolving the perception of what a CDMO should be
- TriRx is continuously expanding its portfolio of world-class facilities to anticipate and meet customer needs
- Committed to openness, honesty, and transparency, TriRx gives customers total access to its people and processes
Related Content
Trending on Pharmaceutical Technology
1
FDA Chooses 7 Companies for PreCheck Pilot
2
Documentation Reliability Across Contractors: A Quality Systems Approach
3
FDA Grants First-in-Class Approval for Treg Cell Therapy in Blood Cancer Transplant Patients
4
Preparing for Pharma’s “Y2K Moment”: What the Shift to a 12-Digit NDC Means for Manufacturers
5